Open AccessDMD, RIPK3, and MLKL gene editing by CRISPR Cas9 as myofiber protection against dystrophin deficiency and necroptosis in Duchenne muscular dystrophy: A literature review
Author(s) -
Jordan Steven Widjaja,
Arga Setyo Adji,
Vira Aulia Kusuma Wardani,
Eilien Levina Santoso,
Fadhilla Rachmawati Sunarto,
Fitri Handajani,
Firman Suryadi Rahman
Publication year - 2022
Publication title -
international journal of health sciences
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns6.10886
Subject(s) - necroptosis , duchenne muscular dystrophy , dystrophin , genome editing , crispr , muscular dystrophy , myocyte , medicine , cas9 , biology , bioinformatics , programmed cell death , genetics , microbiology and biotechnology , gene , apoptosis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom